R&D Improving treatment for high-risk cataract surgery Cataracts rank among the most prevalent age-related ailments.
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
